526 related articles for article (PubMed ID: 26875941)
1. Overuse of external beam radiotherapy for stage I endometrial cancer.
Wright JD; Margolis B; Hou JY; Burke WM; Tergas AI; Huang Y; Hu JC; Ananth CV; Neugut AI; Hershman DL
Am J Obstet Gynecol; 2016 Jul; 215(1):75.e1-7. PubMed ID: 26875941
[TBL] [Abstract][Full Text] [Related]
2. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
Alektiar KM; Venkatraman E; Chi DS; Barakat RR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant Pelvic Radiation Therapy±Vaginal Brachytherapy in Patients With High-risk Stage I or Stage II Uterine Papillary Serous, Clear Cell, and High-grade Endometrioid Carcinoma.
Nagar H; Yan W; Parashar B; Nori D; Chao KS; Christos P; Gupta D; Holcomb K; Caputo T; Wernicke AG
Am J Clin Oncol; 2016 Aug; 39(4):335-9. PubMed ID: 27028349
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant radiotherapy for stage I endometrial cancer.
Kong A; Johnson N; Kitchener HC; Lawrie TA
Cochrane Database Syst Rev; 2012 Mar; (3):CD003916. PubMed ID: 22419290
[TBL] [Abstract][Full Text] [Related]
5. Impact of vaginal brachytherapy on survival in stage I endometrioid endometrial carcinoma.
AlHilli M; Amarnath S; Elson P; Rybicki L; Dowdy S
Int J Gynecol Cancer; 2020 Jun; 30(6):789-796. PubMed ID: 32184268
[TBL] [Abstract][Full Text] [Related]
6. The impact of adjuvant vaginal brachytherapy in women with Stage II uterine endometrioid carcinoma: Results of a National Cancer Database analysis.
Lee JK; Ghanem AI; Modh A; Burmeister C; Mahmoud O; Maxwell GL; Elshaikh MA
Brachytherapy; 2018; 17(2):319-325. PubMed ID: 29174935
[TBL] [Abstract][Full Text] [Related]
7. Impact of different adjuvant radiotherapy modalities on women with early-stage intermediate- to high-risk endometrial cancer.
Jin M; Hou X; Sun X; Zhang Y; Hu K; Zhang F
Int J Gynecol Cancer; 2019 Oct; 29(8):1264-1270. PubMed ID: 31320487
[TBL] [Abstract][Full Text] [Related]
8. Radiation therapy improves disease-specific survival in women with Stage II endometrioid endometrial cancer-Brachytherapy may be sufficient.
Nwachukwu CR; Von-Eyben R; Kidd EA
Brachytherapy; 2018; 17(2):383-391. PubMed ID: 29198879
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant radiotherapy for stage I endometrial cancer.
Kong A; Johnson N; Kitchener HC; Lawrie TA
Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD003916. PubMed ID: 22513918
[TBL] [Abstract][Full Text] [Related]
10. Single-institutional outcomes of adjuvant brachytherapy for Stage I endometrial cancer-Are outcomes consistent with randomized studies?
Dohopolski MJ; Horne ZD; Gebhardt BJ; Glaser SM; Edwards RP; Kelley JL; Comerci JT; Olawaiye AB; Courtney-Brooks M; Berger JL; Sukumvanich P; Beriwal S
Brachytherapy; 2018; 17(3):564-570. PubMed ID: 29426745
[TBL] [Abstract][Full Text] [Related]
11. Patterns of care in women with high-intermediate risk endometrioid adenocarcinoma in the PORTEC-2 era: A SEER database analysis.
Zavitsanos PJ; Leonard KL
Brachytherapy; 2017; 16(1):109-115. PubMed ID: 27780688
[TBL] [Abstract][Full Text] [Related]
12. Survival benefit of radiation in high-risk, early-stage endometrioid carcinoma.
Xiang M; Kidd EA
J Gynecol Oncol; 2020 Jul; 31(4):e39. PubMed ID: 31912686
[TBL] [Abstract][Full Text] [Related]
13. Lymphadenectomy influences the utilization of adjuvant radiation treatment for endometrial cancer.
Sharma C; Deutsch I; Lewin SN; Burke WM; Qiao Y; Sun X; Chao CK; Herzog TJ; Wright JD
Am J Obstet Gynecol; 2011 Dec; 205(6):562.e1-9. PubMed ID: 22030315
[TBL] [Abstract][Full Text] [Related]
14. Factors Predictive of Receiving Adjuvant Radiotherapy in High-Intermediate-Risk Stage I Endometrial Cancer.
McGunigal M; Pollock A; Doucette JT; Liu J; Chadha M; Kalir T; Gupta V
Int J Gynecol Cancer; 2018 Jun; 28(5):882-889. PubMed ID: 29538253
[TBL] [Abstract][Full Text] [Related]
15. Patterns of adjuvant radiation usage and survival outcomes for stage I endometrial carcinoma in a large hospital-based cohort.
Wong AT; Rineer J; Schwartz D; Weiner J; Safdieh J; Choi K; Schreiber D
Gynecol Oncol; 2017 Jan; 144(1):113-118. PubMed ID: 27823769
[TBL] [Abstract][Full Text] [Related]
16. Definitive Radiation Therapy for Stage I-II Endometrial Cancer: An Observational Study of Nonoperative Management.
Yoo S; Hegarty SE; Mishra MV; Patel N; Cantrell LA; Showalter TN
Am J Clin Oncol; 2017 Dec; 40(6):582-589. PubMed ID: 26083557
[TBL] [Abstract][Full Text] [Related]
17. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial.
Nout RA; Smit VT; Putter H; Jürgenliemk-Schulz IM; Jobsen JJ; Lutgens LC; van der Steen-Banasik EM; Mens JW; Slot A; Kroese MC; van Bunningen BN; Ansink AC; van Putten WL; Creutzberg CL;
Lancet; 2010 Mar; 375(9717):816-23. PubMed ID: 20206777
[TBL] [Abstract][Full Text] [Related]
18. Improved overall survival with adjuvant radiotherapy for high-intermediate and high risk Stage I endometrial cancer.
Harkenrider MM; Adams W; Block AM; Kliethermes S; Small W; Grover S
Radiother Oncol; 2017 Mar; 122(3):452-457. PubMed ID: 28012794
[TBL] [Abstract][Full Text] [Related]
19. Does brachytherapy improve survival in addition to external beam radiation therapy in patients with high risk stage I and II endometrial carcinoma?
Crosby MA; Tward JD; Szabo A; Lee CM; Gaffney DK
Am J Clin Oncol; 2010 Aug; 33(4):364-9. PubMed ID: 20689365
[TBL] [Abstract][Full Text] [Related]
20. Stage II endometrial carcinoma: limiting post-operative radiotherapy to the vaginal vault in node-negative tumors.
Rittenberg PV; Lotocki RJ; Heywood MS; Krepart GV
Gynecol Oncol; 2005 Sep; 98(3):434-8. PubMed ID: 16005498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
